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I. ABSTRACT
CD4+ T cells and CD40, highly expressed in activated microglia, along with
microglia

themselves

have

been

demonstrated

to

contribute

to

mechanical

hypersensitivity in a murine model of neuropathic pain, spinal nerve L5 transection
(L5Tx).

This study investigated whether CD4 and CD40 mediate their effects by

affecting spinal cord microglial responses and/or leukocyte infiltration into the spinal
cord. L5Tx was performed on wild type (WT), CD4 knockout (KO), and CD40 KO
mice.

Mononuclear cells from the lumbar spinal cord were collected and the total

number of microglia (CD45loCD11b+) and infiltrating leukocytes (CD45hi) were analyzed
in a time course study via flow cytometry. In WT mice, L5Tx significantly increased the
total number of microglial cells in the ipsilateral side of the lumbar spinal cord at day 3
and day 7 post-surgery. Similar changes in microglial numbers were observed in CD4
KO mice at day 7 post-L5Tx but not in CD40 KO mice. Post-L5Tx, WT mice displayed
elevated numbers of infiltrating leukocytes in the ipsilateral side of the lumbar spinal
cord. Only minimal increases in infiltrating leukocytes were found in CD4 KO and
CD40 KO mice. The current data suggest CD40 may have greater involvement than CD4
in peripheral nerve injury-induced neuropathic pain.
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II. INTRODUCTION
The quality of life for many across the globe has been severely impacted by
neuropathic pain, one of the most debilitating manifestations of chronic pain.

The

prevalence rates of neuropathic pain from general population studies have ranged from
estimates of 1-2% up to 8% worldwide (Smith and Torrance 2010). However, such pain
is often left untreated or mistreated. As a result, long-term disability and depression are
common as is the overuse of diagnostic services and procedures, hospitalizations,
surgery, and inappropriate medication (DeLeo and Winkelstein 2002). Opioids such as
methadone or morphine are often prescribed to temporarily alleviate pain sensations by
binding to opioid-specific receptors in the central and peripheral nervous systems to
inhibit nociceptive activity (DeLeo and Winkelstein 2002). While drugs like opioids are
effective at reducing the perception of pain, they also are highly addictive and can cause
severe withdrawal symptoms such as tremors, nausea, and anxiety.

Tricylclic

antidepressants (TCAs) such as amitriptyline, imipramine, and nortriptyline have also
proved effective at reducing neuropathic pain symptoms (Gelder et al. 2005). However,
in overdose, TCAs are cardiotoxic, prolonging heart rhythms and increasing myocardial
irritability usually leading to death (Gelder et al. 2005). By using animal models, the
biological mechanisms underlying neuropathic pain may be better examined to help
develop efficient medicinal treatment options accompanied by less detrimental
consequences.
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II.1 Neuropathic Pain
To comprehend the features of neuropathic pain, it is first necessary to explain
how pain is generated and identify its two main types (acute and chronic). The induction
of nociception occurs when specific stimuli evoke a response activating specialized areas
on nociceptive nerve terminals. The terminals encourage electrical impulse (or action
potential) conduction, along the nociceptive fiber to the spinal cord dorsal horn (Milligan
and Watkins 2009).

The electrical signals then enter the brain from the spinal cord

where the sensation may be perceived as a state of pain and expressed as either acute or
chronic depending on the signals' duration.

Acute pain is an essential defense

mechanism warning against existing or imminent damage to the physiological
functioning of the normal body system (Tsuda et al. 2005). In contrast, chronic pain is
considered a reflection of atypical functioning of a pathologically altered nervous system,
serving no established defensive or otherwise helpful function (Tsuda et al. 2005). The
duration of chronic pain lasts longer than any identifiable continuous injury or
inflammation (Wang and Wang 2003).

One kind of chronic pain, identified as

“neuropathic,” is initiated by a primary lesion or dysfunction expressed in the nervous
system (Backonja 2003). Neuropathic pain is often manifested when peripheral nerves
are damaged through surgery, bone compression in cancer, diabetes, “channelopathies,”
and autoimmune diseases (Tsuda et al. 2005, Campbell and Meyer 2006). Common
sensations reported by patients include those of burning, tingling, electric shock-like, or
“pins and needles” (Galluzzi 2005). These feelings may develop due to an altered or
inhibited pain perception pathway when a damaged nerve cannot properly send electrical
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signals from the peripheral nervous system (PNS) to the central nervous system (CNS)
and vice-versa. While nerve regeneration is often attempted, there is great risk the
affected neurons will become sensitized and display low thresholds of excitability,
thereby firing impulses more often. Several symptoms of this agonizing state include
spontaneous pain, or pain independent of a stimulus; hyperalgesia, an increased response
to noxious stimuli; and allodynia, a pain response to normally innocuous stimuli
(Moalem et al. 2004). In several studies using the spinal nerve L5 transection (L5Tx)
murine model of neuropathic pain, subjects displayed significant mechanical allodynia
along with thermal and mechanical hyperalgesia for a duration of at least four weeks
(Tanga et al. 2005, Cao et al. 2009a). By using this model to mimic neuropathic pain, it
was found that inflammation in the CNS and resulting neuroimmune activation, proposed
to be by way of glia and infiltrating leukocytes, could influence behavioral
hypersensitivity at least in animals (DeLeo et al. 2004). Due to neuropathic pain's
association with such a wide array of diseases and disorders, the study of the CNS's
immunological responses to lesions/disruptions associated with neuropathic pain may
provide the information required to develop improved avenues of treatment.

II.2 Microglia
When a nerve injury occurs, the resulting molecular and cellular changes may
influence neuronal plasticity and anatomical reorganization throughout the peripheral and
central nervous systems (Woolf and Salter 2000).

An injured CNS may use

inflammation, an inherent immune response, to detect and rapidly react to microbial
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invasion or chemical/physical lesions (Muzio et al. 2007). Microglia, one type of glial
cell derived from bone marrow, produce some of the first notable active immune
responses (DeLeo and Yezierski 2001). These cells limit nerve damage in a manner
similar to that of tissue macrophages as both cell types are derived from monocytes.
Microglia initiate CNS tissue repair for the clearance of apoptotic cells and toxic debris
such as free-floating myelin, amyloid fibrils, and fragmented neurons (Muzio et al. 2007).
Microglia exist in two functional states: surveillance and activation. Microglial
cells in healthy tissue allow their cell bodies to remain at rest while their fine branching
processes undergo continuous rebuilding (Hanisch and Kettenmann 2007). This limited
motion is used to constantly scan their territory and prepare their receptors for adjacent
neuronal/glial signaling (Hanisch and Kettenmann 2007).

An influx of infectious

microbes (possibly projecting a specific ligand that can bind to receptors such as P2X4
and toll-like receptor 4 (TLR4)), ATP released from dead cells, and serum factors leaking
out into the extracellular environment resulting from a breakdown of the blood spinal
cord/brain barrier or severe tissue damage (a disruption in signaling) may activate the
microglia (Tsuda et al. 2003, Hanisch and Kettenmann 2007, Eroglu and Barres 2010).
While surveillance microglia appear somewhat stationary, activated microglia are able to
identify an injured site and accumulate there.

Here, the microglia proliferate,

phagocytose dead/dying cells and debris, express activation surface molecules (such as
major histocompatibility complex (MHC) class II, CD11b, B7.2, and CD40), and secrete
soluble proinflammatory cytokines and chemokines upon the activation of TLRs
(Sweitzer et al. 2002, Cao and DeLeo 2008a, Zhu and Paul 2008, Cao et al. 2009a).
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While each of these actions appears beneficial for the healing and protection of damaged
tissue, there is growing evidence to suggest that continued microglial activation may be
detrimental to the elimination of neuronal pain signaling.

II.3 CD40 and Neuropathic Pain
As microglia are activated in the CNS, they become antigen-presenting cells
(APCs) and display elevated CD40 expression (Kornbluth 2000). CD40 is classified as a
48kD cell surface receptor in the tumor necrosis factor (TNF) receptor superfamily that is
activated by CD40 ligand (CD154) (Grewal and Flavell 1998). Besides being present in
microglial cell systems, CD40 is also expressed by B cells, macrophages, Langerhans
cells, endothelial cells, and thymic epithelial cells (Togo et al. 2000). It is known that
CD40-CD154 ligation activates a series of microglial signaling pathways that include the
release of nitric oxide (NO), the expression of cyclooxygenase-2, the secretion of
chemokines/cytokines (IL-10, IL-12, TNFα, IFNγ, MCP-1), and increased antigen
presentation (Matyszak et al. 1999, Tan et al. 1999, Jana et al. 2001, D’Aversa et al. 2002,
Okuno et al. 2004, Townsend et al. 2005). Increased CD40 expression is often observed
in several CNS diseases including multiple sclerosis, Alzheimer's disease, amyotrophic
lateral sclerosis, and HIV-1 encephalitis (Togo et al. 2000, Cao et al. 2009a). Microglia
expressing CD40 at sites of nerve damage are linked to the development of mechanical
hypersensitivity in a neuropathic pain model (Cao et al. 2009a). However, the exact
mechanism underlying such CD40 association is not well understood.
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II.4 CD4+ T Cells and Neuropathic Pain
In general, there are two major types of T cells, CD4+ and CD8+ T cells, with a
ratio between these two groups at approximately 2:1. While T cells, like microglia,
originate in bone marrow, they become mature in the thymus before leaving to assist in
adaptive immunity (Schwarz and Bhandoola 2006). CD4+ T cells are the center of the
adaptive immune response. During an immune response, CD4+ T cells differentiate into
at least two subsets (type 1 and type 2 helper T cells) with different functional capabilities
and cytokine profiles (Mosmann et al. 1986). CD4+ T cells are able to help B cells make
antibodies, influence the development of enhanced microbicidal activity by macrophages,
recruit other white blood cells to sites of infection and inflammation, and, by producing
proinflammatory cytokines and chemokines, coordinate extensive immune protection
(Zhu and Paul 2008). In several studies it has been shown that while T cells, particularly
CD4+ T cells, attempt to gather more immunological support to respond to nerve injury,
they actually contribute to the nociceptive hypersensitivity associated with neuropathic
pain (Moalem et al. 2004, Cao and DeLeo 2008b, Costigan et al. 2009). In Moalem's
study (2004), the systematic adoptive transfer of type 1 helper CD4+ T cells (one subgroup of CD4+ T cells) to nerve-injured nude rats reinstated allodynia. These results
were further supported by Cao and DeLeo's study (2008b) showing that attenuated
allodynia in CD4 KO mice could be restored through the systematic adoptive transfer of
CD4+ T cells.
In addition, following peripheral nerve injury, CD4+ T cells tend to migrate
toward areas of microglial activation suggesting a link between the infiltration of CD4+ T
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cells and microglia (Cao and DeLeo 2008b). It has been suggested that CD4+ T cells are
able to enter the CNS through the blood-spinal cord barrier using leukocyte
extravasation, a process involving rolling and later tight adhesion by immune cells
(Gordh et al. 2006, Costigan et al. 2009). These actions involve various proinflammatory
cytokines and chemokines, eventually leading to endothelial transmigration (Costigan et
al. 2009). Due to the presence of ligand CD154 on the activated CD4+ T cells and their
rapid trafficking into sites of degradation alongside activated microglia, it has been
theorized that the CD40-CD154 interaction contributes to CD4+ T cell and microglia
immune signaling.

II.5 CD40-CD154 Interaction
The interaction of CD40 with its ligand CD154, a 34-39 kD surface protein
primarily present on activated CD4+ T cells, allows for the development of the acquired
immune response, including both humoral and cell-mediated immune responses
(Quezada et al. 2004). The CD40-CD154 interaction is associated with the release of
several chemokines and cytokines which could potentially signal infiltrating leukocytes
including T cells. The pathway's influence on neuropathic pain manifestation has not yet
been thoroughly investigated.

However, by determining the temporal and spatial

relationship between CD40+ microglia and infiltrating CD4+ T cells in a nerve-damaged
section of the CNS, it may help to identify key signaling components of the CD40CD154 interaction that influence the progress of the chronic pain state.
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II.6 Murine Models of Neuropathic Pain
Over the years, several models of neuropathic pain have been developed in
rodents to mimic chronic pain that later provokes extensive behavioral hypersensitivity,
as experienced by humans (Wang and Wang 2003). Both central and peripheral pain
models have been shown to be effective in producing behaviors reflective of the
neuropathic pain state. Peripheral nerve injury-induced neuropathic pain usually involves
manipulation (nerve ligation (clamping), cryoneurolysis (freezing), and transection
(severance)) of selected peripheral nerves such as sciatic or spinal nerves (Wang and
Wang 2003).
The model of neuropathic pain utilized in the current study is the spinal nerve L5
transection (L5Tx). The L5Tx protocol is widely used based upon its inter-experimenter
reliability through the surgical procedure. This model has been shown to produce robust
mechanical and thermal hypersensitivity (including both allodynia and hyperalgesia) as
well as activation of both astrocytes and microglia in the lumbar spinal cord (DeLeo and
Winkelstein 2002, Sweitzer et al. 2002). Recently, it was demonstrated that there are
significant increases of CD40+ microglia and infiltrating CD4+ T cells in the lumbar
spinal cord post-L5Tx and that both microglial CD40 and CD4+ T cells contribute to the
maintenance of L5Tx-induced mechanical hypersensitivity, with an earlier involvement
of microglial CD40 than CD4+ T cells (Cao and DeLeo 2008b, Cao et al. 2009a).
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III. HYPOTHESIS AND SPECIFIC AIMS
This research was designed to investigate the mediating effects of CD4 and CD40
on L5Tx-induced microglial responses and leukocyte infiltration in the lumbar spinal
cord. It was hypothesized that L5Tx significantly increases the numbers of microglia and
infiltrating T cells in the ipsilateral side of the lumbar spinal cord post-L5Tx in wild type
(WT) mice, while reduced numbers of microglia and/or infiltrating leukocytes would be
observed in CD4 KO and CD40 KO mice post-L5Tx. The hypothesis was tested through
two specific aims: 1) To determine total numbers of microglia present in the lumbar
spinal cord over a specific time period post-L5Tx in WT, CD40 KO, and CD4 KO mice;
and 2) To determine total numbers of infiltrating leukocytes present in the lumbar spinal
cord of these genotypes over a specific time interval post-L5Tx. In addition, both CD40
and CD4 play their roles primarily in the maintenance phase of neuropathic pain in the
L5Tx model of neuropathic pain (Cao and DeLeo 2008b, Cao et al. 2009a).

The

involvement of microglia interacting with infiltrating leukocytes in the development of
neuropathic pain can be further elucidated from this study.
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IV. METHODS
IV.1 Experimental Design
During previous studies, increased microglial CD40 surface molecule expression
was observed at day 3 and day 7 post-L5Tx and the most significant leukocyte infiltration
was seen to occur on day 7 post-L5Tx with CD4+ T lymphocytes as the main infiltrating
type of cell (Cao and DeLeo 2008b, Cao et al. 2009a). In the current study, mice of three
genotypes (WT, CD40 KO, and CD4 KO) were used. Three to five animals were
randomly divided into either the L5Tx group or the sham surgery group. At selected
times (days 0, 1, 3, 7, and 14 post-surgery), lumbar spinal cord mononuclear cells were
harvested, categorically pooled, and analyzed via flow cytometry using monoclonal
antibodies (mAbs) against CD45 and CD11b. CD45, a protein tyrosine phosphotase,
regulates sarcoma kinases required for T and B cell receptor signal transduction. It is
expressed by all types of leukocytes, including microglia (Kung et al. 2000). It has been
established that CD45 can be used as a marker to distinguish infiltrating leukocytes from
the CNS resident, monocyte-derived microglia by flow cytometry, with CD45hi (high
level of CD45 expression) representing infiltrating leukocytes and CD45lo (low level of
CD45 expression) indicating microglia (Badie and Schartner 2000, Ford et al. 1995,
Sedgwick et al. 1991). CD11b, a component of complement receptor 3 (CR3), is an
antigen characteristic of mature bone marrow-derived myeloid cells including microglia
(Prakash et al. 1998). Thus, in this study, a low level of CD45 expression and positive
expression of CD11b (CD45loCD11b+) together are used to identify microglia and a high
level of CD45 expression (CD45hi) is used to identify infiltrating leukocytes (Figure 1).
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Figure 1. Experimental Design (Please see text for detail).

IV.2 Animals
Mice were housed in groups of three, four, or five according to sex in standard
isolation cages with food and water available ad libitum. Cages were changed once a
week and after each surgery to avoid contamination and prevent infection of surgical
wounds. The Institutional Animal Care and Use Committee (IACUC) at UNE approved
all experimental procedures used in this research. In this study, three types of mice were
used. Adult WT BALB/c mice were purchased from the National Cancer Institute (NCI,
Frederick, MD, USA). The animals were allowed to habituate for at least one week in the
animal facility before use in experimentation. Breeding pairs for BALB/c CD4 KO mice
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were originally obtained from Dr. William Lee in the Wadsworth Center of the New York
State Department of Health, bred in the Dartmouth-Hitchcock Medical Center, and are
currently maintained in the UNE animal facility. Breeding pairs for BALB/c CD40 KO
mice were originally obtained from the Jackson Laboratory (Bar Harbor, ME, USA) and
bred in the animal facility at UNE. Mice were 8-10 weeks old upon the initiation of each
experimental procedure. Both CD4 KO and CD40 KO mice are immunocompromised
due to the loss of molecules critical in eliciting effective adaptive immune responses. In
particular, CD4 KO mice lack mature CD4+ T cells (Ganta et al. 2004). However,
possible changes in the numbers of CNS glial cells (including both microglia and
astrocytes) have not been investigated previously. Both male and female mice were used
throughout the current study.

In previous studies, no differences in L5Tx-induced

mechanical hypersensitivity were observed between the sexes in WT, CD4 KO, or CD40
KO mice (Cao and DeLeo 2008b, Cao et al. 2009a). Also, at the basal level, there were
no differences in mechanical sensitivity among these mice.

IV.3 Spinal Nerve L5 Transection (L5Tx)
Three to five WT, CD40 KO, or CD4 KO mice were randomly selected into L5Tx
surgery, sham surgery, and naïve (no surgery) groups. L5Tx and sham surgeries were
performed, as previously described by Cao et al. (2008b), using aseptic techniques. The
animals were anesthetized with isoflurene (4% for induction and 2.5% for maintenance)
delivered in oxygen at a flow rate of 70 vol/min. Prior to the surgery for each mouse, the
hair of the lower back was removed and the area was cleaned with betadine. A 1-2 cm
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long incision was made along the mid-line of the back over the L5-L6 vertebra area.
Muscle fibers were pulled away from the L6 transverse process and both spinal nerves L4
and L5 were exposed. L5 was transected and a 0.5-1 mm piece of the severed L5 was
removed to prevent the nerve from reconnecting. For mice undergoing sham surgery, the
L5 was only exposed and not transected. The incision was flushed with sterile saline
before closure. The fascia and muscle layers were sutured using the soft silk 6-0 suture.
The skin was closed with 3-0 sutures.

IV.4 Lumbar Spinal Cord Mononuclear Cell Preparation
Prior to euthanization, the animals were massed and inspected for any unexpected
abnormalities that may have developed following surgery or while held in the animal
facility. Mice were euthanized by CO2 asphyxiation and transcardially perfused with a
0.1 M phosphate-buffered saline (PBS, pH 7.4; between 50 and 150 ml per mouse). After
decapitation, the spinal cord was harvested from each individual mouse. The lumbar
enlargement portion of the spinal cord (L4-L6) was isolated and separated into ipsilateral
and contralateral (relative to injury) segments. Lumbar spinal cord mononuclear cells
were further prepared according to a previously published method (Cao and DeLeo
2008b). Lumbar spinal cord pieces from 3-5 animals (same treatment and same side of
the lumbar spinal cord) were pooled together, homogenized in PBS, filtered through a 70
µm cell strainer (BD Biosciences, San Diego, CA, USA) and pelleted through
centrifugation. In order to obtain mononuclear cells from the spinal cord tissue, Percoll
gradients of 40% and 70% were used (800 g at 24°C for 40 minutes, without braking).
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Cells below the 40% Percoll layer and above the 70% Percoll layer were collected. The
total cell number of each sample was determined by using a hemocytometer with Trypan
Blue (Sigma, St. Louis, MO, USA) before staining for flow cytometric analysis.

IV.5 Flow Cytometry
The collected mononuclear cells were labeled with mAbs for flow cytometric
analysis following a published procedure (Cao and DeLeo 2008b). To prevent nonspecific binding, cell surface Fc receptors were blocked with staining buffer (2% fetal
bovine serum and 0.09% NaN3 in PBS) containing anti-mouse-CD16/CD32 (2.4G2, BD
Biosciences). After 30 minutes of incubation, combinations of fluorescence-labeled
mAbs: APC-anti mouse CD45 (clone 30-F11 eBiosciences) and PE-anti mouse CD11b
(clone M1/70 eBiosciences) were added to each tube. The cells were then incubated on
ice for another 30 minutes. The cells were washed twice with PBS and centrifuged at
2000 g at 4°C for 5 minutes each.

All labeled cells were re-suspended in 1%

formaldehyde/PBS and kept on ice until analysis. All samples were analyzed using an
Accuri C6 flow cytometer with CFlow software (Accuri Cytometers Inc., Ann Arbor, MI,
USA). Non-stained cells were included in each run as controls. All files collected with
the flow cytometer were further analyzed using the FlowJo 7.6 (tree Star, Sanford, NJ,
USA). During data analysis, total cell population was identified based on the FSC
(forward scatter) vs. SSC (side scatter) plot of each sample (Figure 2 top panel). FSC is
mostly diffracted light from the cell and is proportional to cell-surface area or size; SSC
is mostly refracted and reflected light and is proportional to cell granularity or internal
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complexity. As described in section IV.1 and in previous studies (Cao and DeLeo 2008b,
Cao et al. 2009a), cells with low levels of CD45 expression and positive for CD11b
(CD45loCD11b+) were identified as microglial cells (Figure 2 lower left), and cells with
high levels of CD45 expression (CD45hi) were identified as infiltrating leukocytes
(Figure 2 lower right). For each sample, the total numbers of microglial cells and
infiltrating leukocytes were further calculated based on the respective percentages of
these populations within the total cells of each sample (obtained via flow cytometric
analysis) and the total number of cells of each sample (obtained via counting using a
hemocytometer – See Section IV.4).

s

Figure 2. Phenotypes of Lumbar Spinal Cord Microglia and Infiltrating Leukocytes.
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Mononuclear cells were isolated from pooled lumbar spinal cord tissue (3-5 mice per
group) at days 0, 1, 3, 7, and 14 post-sham or L5Tx surgery. Mononuclear cells were
stained with mAbs, APC-anti mouse CD45 and PE-anti mouse CD11b to identify cell
populations of interest via flow cytometric analysis. An example of how each sample
was analyzed is shown in Figure 2 using a sample collected from the ipsilateral side of
the lumbar spinal cord of WT mice at day 7 post-L5Tx. On the top, a typical FSC vs.
SSC plot of each sample is shown and the total mononuclear cell population is identified
as “Total cells”. On the lower left side, “Total cells” are shown in the CD11b vs. CD45
plot and microglia (CD45loCD11b+) are identified. On the lower right side, “Total cells”
are shown in the SSC vs. CD45 plot and infiltrating leukocytes (CD45hi) are identified.

IV.6 Statistical Analysis
The SigmaPlot 10.0 (Systat Software, San Jose, CA, USA) was used to graph the
data and statistical analyses were performed with the SigmaStat 3.5 (Systat Software).
One-way analysis of variance (ANOVA) was performed and followed by the StudentNewman-Keuls (SNK) post hoc test. All data are presented as mean ± SEM when
applicable. Statistical significance was defined at p < 0.05.
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V. RESULTS
V.1 Total Numbers of Microglia in the Lumbar Spinal Cord Post-L5Tx

Activated microglia have been shown to proliferate and migrate to areas of injury
to help phagocytose debris and produce several bioactive molecules (Langmann, 2007).
To begin investigating the role of CD4 (particularly, CD4+ T cells) and CD40 in lumbar
spinal cord microglial responses following L5Tx-induced neuropathic pain, an
examination of total numbers of microglia in the lumbar spinal cord subsequent to both
L5Tx and sham surgery in WT, CD4 KO, and CD40 KO mice was performed. Adult
male and female BALB/c mice with different genotypes (WT, CD4 KO, or CD40 KO)
were subjected to either L5Tx or sham surgery. Lumbar spinal cord mononuclear cells
were harvested (pooled from 3-5 mice for each treatment) at specific time points postsurgery and analyzed via flow cytometry. Changes of the number of total mononuclear
cells are shown in Figure 3. L5Tx induced a general trend of increase in the total
mononuclear cell number at days 3 and 7 in WT mice, particularly in the ipsilateral side
of the lumbar spinal cord. The data for the WT mice represent the average of at least
three sets of experiments and no statistical significance was detected at this time.
CD45loCD11b+ populations were identified as microglial cells and the total number of
microglia from each sample was calculated based on the total number of mononuclear
cells collected from each sample (as illustrated in Figure 2 and detailed in Materials and
Methods, and graphed in Figure 3).

As expected, a distinct, brief increase in the total

number of microglia in the ipsilateral side of the lumbar spinal cord was observed at day
3 (2079.78 ± 1383.30 cells) and day 7 (1707.71 ± 731.12 cells) post-L5Tx compared to
20

the mice subjected to the sham operation. Throughout the study, the sham surgery did
not induce a detectable increase of microglial numbers (Figure 4). Preliminary statistical
analyses with the data thus far from the WT mice using a two-way ANOVA and SNK
post hoc test indicated a significant time effect (ptime = 0.013) and potential group
difference (pgroup = 0.135).
Due to the limited available numbers of CD4 KO and CD40 KO mice, only one
complete experimental set for each of these KO mice was performed. The results suggest
both CD4 and CD40 are involved in microglial responses following L5Tx. In CD4 KO
mice, increased numbers of lumbar spinal cord microglia in the ipsilateral side were
observed only at day 7, not day 3, post-L5Tx compared to the sham surgery (Figure 5).
This elevation appeared to be comparable to that of WT mice at the same time (WT =
1707.71 ± 731.12 cells, CD4 KO = 3380.00 cells). While in CD40 KO mice, the total
number of microglial cells appeared to be less in naïve mice (left side = 189.07 cells, and
right side = 95.22 cells) compared to that of WT (left side = 481.50 ± 243.50 cells, and
right side = 669.34 ± 302.86 cells) and CD4 KO (left side = 469.96 ± 444.48 cells, and
right side = 255.78 ± 200.22 cells) mice. There was also no L5Tx-induced ipsilateral
side-specific increase of total numbers of microglia (Figure 5). Further, unlike WT and
CD4 KO mice, in CD40 KO mice, a trend of increase in the total number of lumbar
spinal cord microglia in both ipsilateral and contralateral sides was noticed in animals
subjected to L5Tx at day 7 and day 14 post-surgery.
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Figure 3: Total numbers of mononuclear cells in the lumbar spinal cord post-L5Tx
in WT, CD4 KO, and CD40 KO mice. Mononuclear cells from pooled lumbar spinal
cord samples (4 per treatment, per side) of each type of mice were collected and counted
using a hemocytometer with trypan blue. Total numbers of mononuclear cells per lumbar
spinal cord (mean ± SEM) are presented. In A, n = 3-4 per group; in B, for “Naïve” and
“Day 14” groups, n = 2, and the rest, n = 1; and in C, n = 1 for all groups. Tx = L5Tx, Sh
= Sham, and Naïve = no surgery was performed; ipsi = ipsilateral side and contra =
Deleted: ¶

contralateral side. For naïve mice, ipsi = left side and contra = right side.
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Figure 4: Total numbers of microglia in the lumbar spinal cord post-L5Tx in WT
mice. Mononuclear cells from pooled lumbar spinal cord samples (4 per treatment, per
side) of WT mice were collected and analyzed via flow cytometry using mAbs against
CD45 and CD11b. A total of 4 independent experiments were performed and at least 3
complete sets of data were collected. Total numbers of microglia (CD45loCD11b+) per
lumbar spinal cord (mean ± SEM) are presented. Tx = L5Tx, Sh = Sham, and Naïve = no
surgery was performed; ipsi = ipsilateral side and contra = contralateral side. For naïve
mice, ipsi = left side and contra = right side.
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Figure 5: Total numbers of microglia in the lumbar spinal cord post-L5Tx in CD4
KO mice.

Mononuclear cells from pooled lumbar spinal cord samples (3-5 per

treatment, per side) of CD4 KO mice were collected and analyzed via flow cytometry
using mAbs against CD45 and CD11b (for “Naïve” and “Day 14” groups, n = 2, and the
rest, n = 1). Total numbers of microglia (CD45loCD11b+) per lumbar spinal cord (mean ±
SEM) are presented. Note that the same scale for the y-axis as that in Figure 4 is used in
order to compare the data collected from mice with different genotypes. Tx = L5Tx, Sh =
Sham, and Naïve = no surgery was performed; ipsi = ipsilateral side and contra =
contralateral side. For naïve mice, ipsi = left side and contra = right side.
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Figure 6: Total numbers of microglia in the lumbar spinal cord post-L5Tx in CD40
KO mice.

Mononuclear cells from pooled lumbar spinal cord samples (3-5 per

treatment, per side) of CD4 KO mice were collected and analyzed via flow cytometry
using monoclonal antibodies against CD45 and CD11b (n = 1).
lo

Total numbers of

+

microglia (CD45 CD11b ) per lumbar spinal cord are presented. Note that the same
scale for the y-axis as that in Figure 4 is used in order to compare the data collected from
mice with different genotypes. Tx = L5Tx, Sh = Sham, and Naïve = no surgery was
performed; ipsi = ipsilateral side and contra = contralateral side. For naïve mice, ipsi =
left side and contra = right side.
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V.2 Total Numbers of Infiltrating Leukocytes in the Lumbar Spinal Cord Post-L5Tx
Infiltrating leukocytes (primarily CD4+ T lymphocytes and macrophages) have
been detected in the lumbar spinal cord following peripheral nerve injury and these
infiltrating leukocytes have been associated with the development of neuropathic pain
(Cao and DeLeo 2008b, Costigan et al. 2009). To examine whether CD4 and CD40 are
involved in the leukocyte infiltration of the lumbar spinal cord following L5Tx, an
analysis of total numbers of lumbar spinal cord infiltrating leukocytes in WT, CD4 KO,
and CD40 KO mice at selected times following either L5Tx or sham surgery was
performed. Flow cytometric data collected from the same samples in the experiment, as
described in V.1, were used in this investigation. CD45hi populations were identified as
infiltrating leukocytes and the total number of infiltrating leukocytes from each sample
was calculated based on the total number of mononuclear cells collected from each
sample (as illustrated in Figure 2 and detailed in Materials and Methods, and graphed in
Figure 3). In WT mice, a noticeable increase of infiltrating leukocytes was detected in
the ipsilateral side of the lumbar spinal cord at days 3 and 7 post-L5Tx but not post-sham
surgery (Figure 7). Preliminary statistical analyses with the data from WT mice using a
two-way ANOVA and SNK post hoc test indicated potential time effect (ptime = 0.115)
and group differences (pgroup = 0.084). In contrast, no significant increase of the numbers
of infiltrating leukocytes was observed at either day 3 or day 7 post-L5Tx in CD4 KO
mice (Figure 8). Similarly, there is no detectable increase of leukocyte infiltration in
CD40 KO mice post-L5Tx (Figure 9).
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Figure 7: Total numbers of infiltrating leukocytes in the lumbar spinal cord postL5Tx in WT mice. Mononuclear cells from pooled lumbar spinal cord samples (4 per
treatment, per side) of WT mice were collected and analyzed via flow cytometry using
mAbs against CD45 and CD11b.

A total of four independent experiments were

performed and at least 3 complete sets of data were collected.

Total numbers of

hi

infiltrating leukocytes (CD45 ) per lumbar spinal cord (mean ± SEM) are presented. Tx
= L5Tx, Sh = Sham, and Naïve = no surgery was performed; ipsi = ipsilateral side and
contra = contralateral side. For naïve mice, ipsi = left side and contra = right side.
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Figure 8: Total numbers of infiltrating leukocytes in the lumbar spinal cord postL5Tx in CD4 KO mice. Mononuclear cells from pooled lumbar spinal cord samples (35 per treatment, per side) of CD4 KO mice were collected and analyzed via flow
cytometry using mAbs against CD45 and CD11b (for “Naive” and “Day 14” groups, n =
2, and the rest, n = 1). Total numbers of infiltrating leukocytes (CD45hi) per lumbar
spinal cord (mean ± SEM) are presented. Note that the same scale for the y-axis as that
in Figure 7 is used in order to compare the data collected from mice with different
genotypes. Tx = L5Tx, Sh = Sham, and Naïve = no surgery was performed; ipsi =
ipsilateral side and contra = contralateral side. For naïve mice, ipsi = left side and contra
= right side.
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Figure 9: Total numbers of infiltrating leukocytes in the lumbar spinal cord postL5Tx in CD40 mice. Mononuclear cells from pooled lumbar spinal cord samples (3-5
per treatment, per side) of CD40 KO mice were collected and analyzed via flow
cytometry using monoclonal antibodies against CD45 and CD11b (n = 1). Total numbers
of infiltrating leukocytes (CD45hi) per lumbar spinal cord are presented. Note that the
same scale for the y-axis as that in Figure 7 is used in order to compare the data collected
from mice with different genotypes. Tx = L5Tx, Sh = Sham, and Naïve = no surgery was
performed; ipsi = ipsilateral side and contra = contralateral side. For naïve mice, ipsi =
left side and contra = right side.
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VI. DISCUSSION
In this study, the mononuclear cells from pooled mouse lumbar spinal cord (L4L6) sections were collected and stained with mAbs for the analysis of microglial and
infiltrating leukocyte numbers in a mouse model of neuropathic pain, L5Tx.

The

experiment thus far has indicated a general trend of activated microglial presence at the
site of injury over a two week period across WT and CD4 KO but not CD40 KO
genotypes. A similar trend for the infiltrating leukocytes was seen in WT mice but not in
the CD4 KO or CD40 KO mice.
As reported previously, an increase of total numbers of lumbar spinal cord
microglia at days 3 and 7 post-L5Tx in the WT mice was observed (Cao 2009b). This is
attributed to an increase in the rapid proliferation and migration towards the site of injury
(specifically, the ipsilateral side of the lumbar spinal cord) of activated microglia. Earlier,
it was demonstrated that both CD4+ T cells and microglial CD40 contribute to the
development of L5Tx-induced mechanical hypersensitivity, particularly during the
maintenance phase (Cao and DeLeo 2008b, Cao et al. 2009a). Reduced total numbers of
spinal cord microglial cells in both CD4 KO and CD40 KO mice following nerve injury
suggest that both CD40 and CD4 can mediate L5Tx-induced mechanical hypersensitivity
through activating microglia.

Interaction between infiltrating CD4+ T cells and

microglia, which may be mediated through CD40 ligation by CD154 on CD4+ T cells,
will be further examined.

It appears CD40 plays a greater role in the microglial

activation than CD4 since an increased number of microglia was found at day 7 postL5Tx in CD4 KO mice, while no significant increase of microglial numbers was
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observed at either day 3 or day 7 post-L5Tx in CD40 KO mice. Moreover, a noticeable
increase of microglial numbers in both ipsilateral and contralateral sides of the lumbar
spinal cord at day 7 and day 14 post-L5Tx was observed in CD40 KO mice. Although
confirmation through further experimentation is necessary, this late increase may suggest
the involvement of other factors in microglial activation. Additionally, the microglial
count for the CD40 KO mice maintained consistently lower values than those observed
for the WT and the CD4 KO mice.

This indicates a potential intrinsic defect in

microglial development may exist and could further contribute to the reduced
hypersensitivity post-L5Tx in CD40 KO mice (Cao 2009a).
As expected, L5Tx induced a significant increase of leukocyte infiltration in WT
mice in the ipsilateral side of lumbar spinal cord, which peaks at day 3 and day 7 postL5Tx. Both CD4+ T cells and macrophages, particularly CD4+ T cells, have been shown
to infiltrate into the spinal cord following peripheral nerve injury and contribute to the
progress of neuropathic pain (Moalem et al. 2004, Cao and DeLeo 2008b, Costigan et al.
2009). Consistent with this, the data showed that CD4 KO mice (that lack CD4+ T cells)
had significantly reduced numbers of infiltrating leukocytes following L5Tx.

The

reduction of infiltrating leukocyte numbers in CD40 KO mice post-L5Tx further suggests
that microglial CD40 is critical in leukocyte infiltration into the spinal cord. Based on the
previous observation by Cao et al. (2009a), 10-20% of activated microglia expressed
detectable CD40.

Reduced CD40-mediated microglial activation and the resultant

reduction of proinflammatory cytokine/chemokine production in CD40 KO mice are the
most likely causes of the decreased leukocyte infiltration. However, indirect effects from
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the interaction between microglia and astrocytes or between microglia and neurons are
also possible (Milligan and Watkins 2009). These relationships may be further examined
in future studies.
Microglia appear to be one type of target cells for T cells upon their infiltration
into the CNS (Costigan et al. 2009). The temporal relationships observed between the
microglial response and the infiltration of leukocytes support an interaction between
microglial CD40 and infiltrating CD4+ T cells, possibly through CD40-CD154 ligation,
following peripheral nerve injury. The CD40-CD154 interaction has been shown to be
involved in the inflammatory and neurotoxic pathways in Alzheimer's disease, multiple
sclerosis, and HIV (Calingasan et al. 2002). Whether CD40-CD154 ligation between
microglia and infiltrating CD4+ T cells plays a role in the pathophysiology of peripheral
nerve injury-induced neuropathic pain will be investigated in the future.
Within the collected mononuclear cells, significant numbers of cells are not
microglia or infiltrating leukocytes (when numbers of total mononuclear cells shown in
Figure 3, numbers of microglial cells in Figures 4-6, and infiltrating leukocytes in Figures
7-9 are compared). However, microglia and infiltrating leukocytes were suggested to be
the major cell types within the mononuclear cells prepared using Percoll gradient
(Ponomarev et al. 2004). It is believed that astrocytes and certain groups of neurons were
also harvested under this experimental condition. Detailed phenotyping of mononuclear
cells will be performed in the future to explain this observation.
Based on the results thus far, besides the continuation of data collection for the
current study, upcoming research may focus on the roles of CD40 and CD4 in other
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aspects of microglial responses following L5Tx. This could be performed using both in
vivo and in vitro approaches.

For example, morphological changes, migration and

proliferation of microglia, expression of selected surface molecules by microglia, and
microglial cytokine/chemokine secretion can be examined.

Further, the interactions

between microglia and astrocytes, microglia and neurons, CD4+ T cells and astrocytes, as
well as CD4+ T cells and neurons, are areas warranting greater investigation. It is known
that there is a significant activation of astrocytes following peripheral nerve injury and it
has been proposed that astrocytes are mainly involved in the maintenance of neuropathic
pain (Milligan and Watkins 2009). In addition, reduced astrocytic response was observed
in CD4 KO mice 7 days post-L5Tx compared to WT mice (Cao and DeLeo 2008b).
Therefore, it is not surprising that multi-cellular interactions can modify neuronal
activities and contribute to the development of neuropathic pain following peripheral
nerve injury.
In summary, the results suggest both CD4 (particularly CD4+ T cells) and CD40
are involved in the development of L5Tx-induced neuropathic pain through the inhibition
of lumbar spinal cord microglial activation and leukocyte infiltration into the spinal cord.
CD40 seems to play a greater role in controlling microglial responses following L5Tx.
Further elucidation of the underlying mechanisms could aid in the development of new
drug targets for the treatment of peripheral nerve injury-induced neuropathic pain.
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